Sarcoma: all 1,691 studies
Page 11 of 17. Open to participants first (393), then studies with results posted, then the rest; newest registration first within each.
- Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue SarcomaWithdrawnNCT03613259Early Phase 1
- Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid TumorsTerminatedNCT03604783Phase 1
- Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related SarcomasActive, not recruitingNCT03600649Phase 1
- Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue SarcomasCompletedNCT03590210Phase 2
- Molecular Profiling to Improve Outcome of Patients in Cancer. A Pilot StudyCompletedNCT03546127
- Assessment of MGMT Promoter Methylation in Advanced Ewing Sarcoma Treated With Temozolomide and IrinotecanCompletedNCT03542097
- Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS StudyStatus unknownNCT03539172Phase 2
- NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue SarcomaTerminatedNCT03524898Phase 1/2
- Burden and Medical Care of Sarcoma in GermanyCompletedNCT03521531
- Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAOCompletedNCT03515174Not applicable
- Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue SarcomaCompletedNCT03514381Phase 4
- Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)No longer availableNCT03493165
- Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label UseCompletedNCT03491371Not applicable
- Long Term Morbidity and Quality of Life in Retroperitoneal SarcomasStatus unknownNCT03480399
- Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and SarcomasActive, not recruitingNCT03478462Phase 1
- Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With RadiotherapyActive, not recruitingNCT03474094Phase 2
- Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's SarcomaStatus unknownNCT03469804Phase 2
- Immunotherapy + Radiation in Resectable Soft Tissue SarcomaCompletedNCT03463408Early Phase 1
- NY-ESO-1-specific T Cell Receptor (TCR) T Cell in SarcomaCompletedNCT03462316Phase 1
- CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced CancersCompletedNCT03454451Phase 1
- US-Guided Biopsy in the Diagnosis of Musculoskeletal Soft-Tissue TumorsCompletedNCT03452644
- Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent SarcomaCompletedNCT03450122Phase 1
- LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue SarcomasActive, not recruitingNCT03449108Phase 2
- QUEST: QUality of Life and Experiences of Sarcoma TrajectoriesStatus unknownNCT03441906
- Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsTerminatedNCT03420963Phase 1
- FAZA PET/MRI SarcomaActive, not recruitingNCT03418818Not applicable
- Anlotinib and Irinotecan for Ewing SarcomaStatus unknownNCT03416517Phase 1/2
- Compression Therapy for Leg Ulcers and Kaposi Sarcoma in Western KenyaCompletedNCT03404297Not applicable
- Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable SarcomaWithdrawnNCT03397186Phase 2
- RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.Active, not recruitingNCT03375437Not applicable
- Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid TumorsActive, not recruitingNCT03373097Phase 1/2
- Irinotecan and Temozolomide for Ewing SarcomaStatus unknownNCT03359005Phase 2
- Clinical Evaluation for Sarcoma Originated From BoneStatus unknownNCT03358992
- Mix Vaccine for Metastatic Sarcoma PatientsCompletedNCT03357315Phase 1/2
- Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue SarcomaWithdrawnNCT03342300Phase 2/3
- Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue SarcomaCompletedNCT03317457Phase 2
- Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi SarcomaCompletedNCT03316274Early Phase 1
- Retrospective Study in Sarcoma PatientsCompletedNCT03284320
- A Study of NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced SarcomaActive, not recruitingNCT03282344Phase 2
- Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone SarcomasCompletedNCT03277924Phase 1/2
- Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing SarcomaCompletedNCT03275818Phase 2
- PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STSStatus unknownNCT03268772Phase 2
- Sarcoma Treatment Guide in Improving Self-Monitoring in Patients With Sarcoma Receiving ChemotherapyCompletedNCT03258892Not applicable
- Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients with Synovial SarcomaCompletedNCT03250325Phase 1/2
- Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced CancerTerminatedNCT03240861Phase 1
- Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS)Status unknownNCT03219671Phase 2
- Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue SarcomaStatus unknownNCT03168061Phase 1/2
- Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.Status unknownNCT03163381Phase 2
- Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in MalawiCompletedNCT03160183
- A Microdose Evaluation Study of ABY-029 in Primary SarcomaCompletedNCT03154411Early Phase 1
- Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue SarcomasWithdrawnNCT03149120Phase 2
- Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot StudyCompletedNCT03144206Phase 4
- PAZIT Study for Children and Young Adults With Relapsed or Refractory SarcomaCompletedNCT03139331Phase 1
- Mobile Self Management and Support for Adolescents and Young Adults With CancerCompletedNCT03130751Not applicable
- Distal Tibia Sarcoma Treatment Using Allograft Arthrodesis of the AnkleStatus unknownNCT03129672
- Mesylate Apatinib for Stage Ⅳ STS After Failure of ChemotherapyStatus unknownNCT03121846Phase 2
- Endostar Combined With Chemotherapy for Stage Ⅳ Soft Tissue SarcomaCompletedNCT03121833Phase 2
- Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue SarcomaTerminatedNCT03116529Phase 1/2
- Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)Active, not recruitingNCT03114527Phase 2
- Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in ChildrenWithdrawnNCT03111069Phase 1
- Use of Propranolol Hydrochloride in the Treatment of Metastatic STSStatus unknownNCT03108300Phase 2
- Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter TrialWithdrawnNCT03104335Phase 2
- A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated LiposarcomaStatus unknownNCT03096912Phase 2
- A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the ExtremityActive, not recruitingNCT03092323Phase 2
- Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and OverActive, not recruitingNCT03077178Not applicable
- A Study Evaluating MM-310 in Patients With Solid TumorsStatus unknownNCT03076372Phase 1
- A Randomized Controlled Study Comparing Priming Solution Containing Crystalloid or Packed Red Blood Cells in Patients Treated With Isolated Limb Perfusion.CompletedNCT03073304Not applicable
- A Phase II Study of Apatinib in STS PatientsStatus unknownNCT03064243Phase 2
- A Study on Safety and Efficacy in Patients With Soft Tissue SarcomasCompletedNCT03058406
- Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue SarcomaCompletedNCT03056599Phase 1
- Smartphone Confocal Microscopy for Diagnosing Kaposi's SarcomaCompletedNCT03050788Not applicable
- Study of Selinexor and Doxorubicin in Advanced Soft Tissue SarcomasCompletedNCT03042819Phase 1
- Single Patient Expanded Access to Ganitumab for Metastatic Ewing SarcomaNo longer availableNCT03029481
- Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS)CompletedNCT03022448
- Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by SurgeryCompletedNCT03009201Phase 1
- Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild HyperthermiaWithdrawnNCT03007771Phase 1
- CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on DoxorubicinStatus unknownNCT03002805Phase 1
- A Study to Compare Adjuvant Concurrent Chemoradiation (CCRT) to Adjuvant Radiation Therapy (RT) in Grade 2 and 3 Extremity Soft Tissue SarcomasCompletedNCT02994264
- Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic TumoursCompletedNCT02992912Phase 2
- European Study in Bone Sarcoma Patients Over 40 YearsCompletedNCT02986503
- Detection of Circulating Tumor Cells in Patients With SarcomasStatus unknownNCT02983539
- Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid TumorsCompletedNCT02982941Phase 1
- A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial CarcinomaStatus unknownNCT02982486Phase 2
- Decitabine and Gemcitabine for Pancreatic Cancer and SarcomaCompletedNCT02959164Phase 1
- Concordance Between Sonography Amd MRI for Presurgical Diagnosis of Uterine Mesenchymal Malignant TumorsTerminatedNCT02940041
- Trabectedin Maintenance Post 1st-line in STSTerminatedNCT02929394Phase 3
- Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by SurgeryActive, not recruitingNCT02923778Phase 2
- Negative Pressure Dressing Therapy in Soft Tissue Sarcoma SurgeryTerminatedNCT02901405Not applicable
- Transcutaneous Oxygen as a Predictor of Wound Healing Complications in Preoperatively Radiated Soft Tissue SarcomaCompletedNCT02897128
- Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803CompletedNCT02890758Phase 1
- Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis FungoidesTerminatedNCT02890368Phase 1
- Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for CancerStatus unknownNCT02856048Phase 2/3
- Combination of Cryosurgery and NK Immunotherapy for Recurrent SarcomaCompletedNCT02849366Phase 1/2
- Study of Abemaciclib in Dedifferentiated LiposarcomaActive, not recruitingNCT02846987Phase 2
- Magnetic Resonance Imaging or Ultrasound in Soft Tissue Tumors (MUSTT)Status unknownNCT02834585
- Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer MedicationsCompletedNCT02833246Not applicable
- Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma TreatmentStatus unknownNCT02812654Phase 2
- Ph II Nintedanib vs. Ifosfamide in Soft Tissue SarcomaTerminatedNCT02808247Phase 2
- Retrospective Study of Trabectedin in Soft Tissue SarcomasCompletedNCT02793050
- Preoperative IMRT for Soft Tissue Sarcoma of the Extremities and Trunk: Low Rate of Wound ComplicationsTerminatedNCT02785692